Could the systemic immune-inflammation index be a predictor to estimate cerebrovascular events in hypertensive

Cihan Aydin1, Şeref Alpsoy1, Aydin Akyüz1

  • 1Department of Cardiology, Faculty of Medicine, Namik Kemal University, Tekirdağ.

Insights

The systemic immune-inflammation index (SII) can predict stroke in hypertensive patients. High SII levels are linked to an increased risk of cerebrovascular events in this population.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Neurology

Background:

  • Hypertension is a major risk factor for cardiovascular and cerebrovascular events.
  • Inflammatory processes play a key role in hypertension pathogenesis and organ damage.
  • Novel inflammatory markers are needed to predict hypertension-related complications.

Purpose of the Study:

  • To investigate the predictive value of the systemic immune-inflammation index (SII) for cerebrovascular events in hypertensive patients.
  • To assess the relationship between SII and stroke risk in individuals with hypertension.

Main Methods:

  • Retrospective analysis of ambulatory blood pressure monitoring data from 379 hypertensive patients.
  • Calculation of SII (platelet × neutrophil/lymphocyte ratio) from complete blood count.
  • Comparison of SII levels between patients with and without a history of stroke.

Main Results:

  • The systemic immune-inflammation index (SII) demonstrated high sensitivity (85.7%) and specificity (84.8%) in predicting stroke.
  • Receiver operating characteristic curve analysis indicated an area under the curve of 0.898 for SII.
  • Multivariate logistic regression revealed that age and SII were significantly associated with an increased stroke risk.

Conclusions:

  • The systemic immune-inflammation index (SII) is a valuable and accessible inflammatory marker for predicting stroke in hypertensive patients.
  • Elevated SII levels are indicative of a higher risk of stroke among individuals with hypertension.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
72
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
139
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
101
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
250
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
131
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
5.4K